Publications

Hong H, Dowdy DW, Dooley KE, Francis HW, Budhathoki C, Han HR, Farley JE

Aminoglycoside-Induced Hearing Loss Among Patients Being Treated for Drug-Resistant Tuberculosis in South Africa: A Prediction Model

Clin Infect Dis, 2019; : pii: ciz28. 10.1093/cid/ciz289

Campbell JR, Dowdy D, Schwartzman K

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries

PLoS Med, 2019; 16(6): e1002824. 10.1371/journal.pmed.1002824

Tampi RP, Tembo T, Mukumba-Mwenechanya M, Sharma A, Dowdy DW, Holmes CB, Bolton-Moore C, Sikazwe I, Tucker A, Sohn H

Operational characteristics of antiretroviral therapy clinics in Zambia: a time and motion analysis

BMC Health Serv Res, 2019; 19(1): 244. 10.1186/s12913-019-4096-z

Hanrahan CF, Nonyane BAS, Mmolawa L, West NS, Siwelana T, Lebina L, Martinson N, Dowdy DW

Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB)

PLoS Med, 2019; 16(4): e1002796. 10.1371/journal.pmed.1002796

Kendall EA, Sahu S, Pai M, Fox GJ, Varaine F, Cox H, Cegielski JP, Mabote L, Vassall A, Dowdy DW

What will it take to eliminate drug-resistant tuberculosis?

Int J Tuberc Lung Dis, 2019; 23(5): 535-546. 10.5588/ijtld.18.0217

Pooran A, Theron G, Zijenah L, Chanda D, Clowes P, Mwenge L, Mutenherwa F, Lecesse P, Metcalfe J, Sohn H, Hoelscher M, Pym A, Peter J, Dowdy D, Dheda K

Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation

Lancet Glob Health, 2019; 7(6): e798-e807. 10.1016/S2214-109X(19)30164-0

Jo Y, Dowdy DW

The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection

Lancet Infect Dis, 2019; pii: S1473-3099(19): 30054-4. 10.1016/S1473-3099(19)30054-4

Sarkar A, Zlojutro A, Khan K, Gardener L

Measles resurgence in the USA: how international travel compounds vaccine resistance

Lancet Infect Dis, 2019; : . 10.1016/S1473-3099(19)30231-2

Nikolay B, Salje H,Hossain MJ, Khan, AKMD, Sazzad HMS, Rahman M, Daszak P, Ströher U, Pulliam JRC, Kilpatrick AM, Nichol ST, Klena JD, Sultana S,Afroj S, Luby SP, Cauchemez S, Gurley ES

Transmission of Nipah Virus — 14 Years of Investigations in Bangladesh

N Engl J Med, 2019; 380: 1804-1814. 10.1056/NEJMoa1805376

Anderson DE, Islam A, Crameri G, Todd S, Islam A, Khan SU, Foord A, Rahman MZ, Mendenhall IH, Luby SP, Gurley ES, Daszak P, Epstein JH, Wang LF

Isolation and Full-Genome Characterization of Nipah Viruses from Bats, Bangladesh

Emerg Infect Dis, 2019; 25(1): 166-170. 10.3201/eid2501.180267

Carstensen LS, Tamason CC, Sultana R, Tulsiani SM, Phelps MD, Gurley ES, Jensen PKM

The Cholera Phone: Diarrheal Disease Surveillance by Mobile Phone in Bangladesh

Am J Trop Med Hyg, 2019; 100(3): 510-516. 10.4269/ajtmh.18-0546

Haque F, Rahman M, Banu NN, Sharif AR, Jubayer S, Shamsuzzaman A, Alamgir A, Erasmus JH, Guzman H, Forrester N, Luby SP, Gurley ES.

An epidemic of chikungunya in northwestern Bangladesh in 2011

PLoS One, 2019; 14(3): e0212218. 10.1371/journal.pone.0212218

Salje H, Paul KK, Paul R, Rodriguez-Barraquer I, Rahman Z, Alam MS, Rahman M, Al-Amin HM, Heffelfinger J, Gurley E

Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates

Elife, 2019; : pii: e428. 10.7554/eLife.42869

Hegde ST, Salje H, Sazzad HMS, Hossain MJ, Rahman M, Daszak P, Klena JD, Nichol ST, Luby SP, Gurley ES

Using healthcare-seeking behaviour to estimate the number of Nipah outbreaks missed by hospital-based surveillance in Bangladesh

Int J Epidemiol, 2019; : pii: dyz05. 10.1093/ije/dyz057

Zlojutro A, Rey D, Gardner L

A decision-support framework to optimize border control for global outbreak mitigation

Sci Rep, 2019; 9(1): 2216. 10.1038/s41598-019-38665-w

Xu Y, Laeyendecker O, Wang R

Cross-sectional HIV Incidence Estimation Accounting for Heterogeneity Across Communities

Biometrics, 2019; : . 10.1111/biom.13046

Rose R, Rodriguez C, Dollar JJ, Lamers SL, Massaccesi G, Osburn W, Ray SC, Thomas DL, Cox AL, Laeyendecker O

Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks

Infect Genet Evol, 2019; 71: 1-6. 10.1016/j.meegid.2019.02.025

Ratmann O, Grabowski MK, Hall M, Golubchik T, Wymant C, Abeler-Dörner L, Bonsall D, Hoppe A, Brown AL, de Oliveira T, Gall A, Kellam P, Pillay D, Kagaayi J, Kigozi G, Quinn TC, Wawer MJ, Laeyendecker O, Serwadda D, Gray RH, Fraser C; PANGEA Consortium and Rakai Health Sciences Program.

Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis

Nat Commun, 2019; 10(1): 1411. 10.1038/s41467-019-09139-4

Sharma S, Schlusser KE, Torre P, Tambussi G, Draenert R, Pinto AN, Metcalf JA, Neaton JD, Laeyendecker O; INSIGHT START Study Group.

The benefit of immediate compared to deferred ART on CD4+ Cell count recovery in early HIV infection

AIDS, 2019; : . 10.1097/QAD.0000000000002219

Solomon SS, Solomon S, McFall AM, Srikrishnan AK, Anand S, Verma V, Vasudevan CK, Balakrishnan P, Ogburn EL, Moulton LH, Kumar MS, Sachdeva KS, Laeyendecker O, Celentano DD, Lucas GM, Mehta SH; Indian National Collaboration on AIDS Study.

Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial

Lancet HIV, 2019; : . 10.1016/S2352-3018(19)30034-7

Houben RMGJ, Lalli M, Kranzer K, Menzies NA, Schumacher SG, Dowdy DW

What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis

Clin Infect Dis, 2019; 68(1): 150-156. 10.1093/cid/ciy544

Yoon C, Semitala FC, Asege L, Katende J, Mwebe S, Andama AO, Atuhumuza E, Nakaye M, Armstrong DT, Dowdy DW, McCulloch CE, Kamya M, Cattamanchi A

Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV

Am J Respir Crit Care Med, 2019; 199(5): 643-650. 10.1164/rccm.201803-0490OC

Cudahy PGT, Andrews JR, Bilinski A, Dowdy DW, Mathema B, Menzies NA, Salomon JA, Shrestha S, Cohen T

Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings

Lancet Infect Dis, 2019; 19(3): e89-e95. 10.1016/S1473-3099(18)30443-2

Dowdy DW

Xpert at 8 years: where are we now, and what should we do next?

J Tuberc Lung Dis, 2019; 23(1): 3-4. 10.5588/ijtld.18.0717

Yoon C, Dowdy DW, Esmail H, MacPherson P, Schumacher SG

Screening for tuberculosis: time to move beyond symptoms.

Lancet Respir Med, 2019; 7(3): 202-204. 10.1016/S2213-2600(19)30039-6

Kasaie P, Schumacher CM, Jennings JM, Berry SA, Tuddenham SA, Shah MS, Rosenberg ES, Hoover KW, Gift TL, Chesson H, German D, Dowdy DW

Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study

BMJ, 2019; 9(3): e023453. 10.1136/bmjopen-2018-023453

Chaisson LH, Semitala FC, Asege L, Mwebe S, Katende J, Nakaye M, Andama AO, Marquez C, Atuhumuza E, Kamya M, Cattamanchi A, Yoon C

Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy

AIDS, 2019; : . 10.1097/QAD.0000000000002130

Azman AS, Lessler J, Luquero FJ, Bhuiyan TR, Khan AI, Chowdhury F, Kabir A, Gurwith M, Weil AA, Harris JB, Calderwood SB, Ryan ET, Qadri F, Leung DT

Estimating cholera incidence with cross-sectional serology

Sci Transl Med, 2019; 11(480): eaau6242. 10.1126/scitranslmed.aau6242

Weill FX, Domman D, Njamkepo E, Almesbahi AA, Naji M, Nasher SS, Rakesh A, Assiri AM, Sharma NC, Kariuki S, Pourshafie MR, Rauzier J, Abubakar A, Carter JY, Wamala JF, Seguin C, Bouchier C, Malliavin T, Bakhshi B, Abulmaali HHN, Kumar D, Njoroge SM, Malik MR, Kiiru J, Luquero FJ, Azman AS, Ramamurthy T, Thomson NR, Quilici ML

Genomic insights into the 2016-2017 cholera epidemic in Yemen

Nature, 2019; 565(7738): 230-233. 10.1038/s41586-018-0818-3

Kendall EA, Azman AS, Maartens G, Boulle A, Wilkinson RJ, Dowdy DW, Rangaka MX

Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting

AIDS, 2019; 33(3): 525-536. 10.1097/QAD.0000000000002053

Omondi FH, Chandrarathna S, Mujib S, Brumme CJ, Jin SW, Sudderuddin H, Miller R, Rahimi A, Laeyendecker O, Bonner P, Yue FY, Benko E, Kovacs CM, Brockman MA, Ostrowski M, Brumme ZL.